1. Home
  2. TANH vs ENTO Comparison

TANH vs ENTO Comparison

Compare TANH & ENTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TANH
  • ENTO
  • Stock Information
  • Founded
  • TANH 2001
  • ENTO 2014
  • Country
  • TANH China
  • ENTO United States
  • Employees
  • TANH N/A
  • ENTO N/A
  • Industry
  • TANH
  • ENTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TANH
  • ENTO Health Care
  • Exchange
  • TANH Nasdaq
  • ENTO Nasdaq
  • Market Cap
  • TANH 2.6M
  • ENTO 2.3M
  • IPO Year
  • TANH 2015
  • ENTO 2016
  • Fundamental
  • Price
  • TANH $1.59
  • ENTO $4.04
  • Analyst Decision
  • TANH
  • ENTO
  • Analyst Count
  • TANH 0
  • ENTO 0
  • Target Price
  • TANH N/A
  • ENTO N/A
  • AVG Volume (30 Days)
  • TANH 189.4K
  • ENTO 385.7K
  • Earning Date
  • TANH 05-15-2025
  • ENTO 11-12-2025
  • Dividend Yield
  • TANH N/A
  • ENTO N/A
  • EPS Growth
  • TANH N/A
  • ENTO N/A
  • EPS
  • TANH N/A
  • ENTO N/A
  • Revenue
  • TANH $42,940,136.00
  • ENTO N/A
  • Revenue This Year
  • TANH N/A
  • ENTO N/A
  • Revenue Next Year
  • TANH N/A
  • ENTO N/A
  • P/E Ratio
  • TANH N/A
  • ENTO N/A
  • Revenue Growth
  • TANH N/A
  • ENTO N/A
  • 52 Week Low
  • TANH $1.45
  • ENTO $0.97
  • 52 Week High
  • TANH $10.77
  • ENTO $5.84
  • Technical
  • Relative Strength Index (RSI)
  • TANH 41.11
  • ENTO 48.54
  • Support Level
  • TANH $1.61
  • ENTO $3.89
  • Resistance Level
  • TANH $1.77
  • ENTO $5.09
  • Average True Range (ATR)
  • TANH 0.14
  • ENTO 0.63
  • MACD
  • TANH -0.01
  • ENTO -0.22
  • Stochastic Oscillator
  • TANH 13.59
  • ENTO 9.30

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

About ENTO Entero Therapeutics Inc. Common Stock

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: